US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

32.03

+0.05100.16%

Volume:3K

Turnover:97.55K

Market Cap:52.01M

PE:- -

High:32.03

Open:32.02

Low:31.75

Close:31.98

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.43

T/O Rate:0.19%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live

Wedbush Adjusts Argenx PT to $1,150 From $1,050, Maintains Outperform Rating

MT Newswires Live

Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results

Argenx SE up over 15%, on Pace for Largest Percent Increase Since July 2023

Argenx rises 14.9%

Sector Update: Healthcare

MT Newswires Live

Argenx price target raised to $1,215 from $1,075 at Piper Sandler

argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study

MT Newswires Live

Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod

Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale

Simply Wall St.

Lifestance Health Q2 Call Highlights Profitable Growth

Major Insider Move at Lifestance Health Group Shakes Up Investor Watchlists

LifeStance Health Director Teresa DeLuca Sells 20,441 Shares Worth $249,991.43

Steris PLC Stock Outperforms Competitors Despite Losses on the Day

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

MT Newswires Live

Major Insider Move Shakes Up Lifestance Health Group

10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million

Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan

Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors

LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/FMED/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":32.0313,"timestamp":1788465600000,"preClose":31.9803,"halted":0,"volume":3058,"delay":0,"changeRate":0.001594731756737802,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Pre-Mkt","change":0.051,"latestTime":"09-04 08:33:25 EDT","open":32.015,"high":32.0313,"low":31.75,"amount":97553.90018,"amplitude":0.008796,"askPrice":51.25,"askSize":200,"bidPrice":12.82,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788528600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":32.0313,"sharesOutstanding":2323806,"nav":31.94992,"aum":51880471.79552,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.93,"preClose":32.0313,"latestTime":"19:30 EDT","volume":8,"amount":256.2504,"timestamp":1788478205282,"change":-0.1013,"changeRate":-0.003163,"amplitude":0},"volumeRatio":0.42518284760336367,"impliedVol":0.0806,"impliedVolPercentile":0.2644},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.42518284760336367,"shares":1623806,"dividePrice":0,"high":32.0313,"amplitude":0.008796,"preClose":31.9803,"low":31.75,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":32.0313,"eps":0,"divideRate":0,"volume":3058,"delay":0,"ttmEps":0,"open":32.015,"prevYearClose":27.05,"prevWeekClose":31.6372,"prevMonthClose":31.775,"prevQuarterClose":28.525,"fiveDayClose":32.4658,"twentyDayClose":28.9763,"sixtyDayClose":25.2105},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660323436","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660323436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660323436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:12","pubTimestamp":1786979555,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and DBV Technologies , which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia  and biopharmaceutical company Cellectis , which advanced 2.5% and 2% respectively.The decliners from continental Europe were led by medical device maker EDAP TMS  and internet browser company Opera , which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which lost 2.4% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and biopharmaceutical company Akari Therapeutics , which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK  and Bicycle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARGX","BCYC","LNOK","BK4007","BK4009","BK4139","AFG","GSK.UK","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0006061336.USD","GSK","UL","ULVR.UK","NCNA","BUD","BK4532","EPV","BUD.AU","LU1983260115.SGD","FMED","GSKH","BK4107","AKTX","WPP","BK4588","UN","DBVT","IE00B4R5TH58.HKD","BK4169","LU0823416689.USD","TBXU","DGE.UK","FOCL","BK4117","IE00BMPRXN33.USD","OPRA","LU0889565916.HKD","BK4592","CLLS","IBB","IEUR","IE00BFTCPJ56.SGD","NOK","WPP.AU","LFGY","DEO","MREO","AUTL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543552","title":"Wedbush Adjusts Argenx PT to $1,150 From $1,050, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543552","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660543552?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:35","pubTimestamp":1786977309,"startTime":"0","endTime":"0","summary":"Argenx (ARGX) has an average rating of buy and mean price target of $1,094.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","IE0034235188.USD","IE00BJJMRZ35.SGD","FMED","LU0823416689.USD","IBB","IE0002141913.USD","IE00B2B36J28.USD","BK4505","LU0109394709.USD","LU0889565916.HKD","LU2324357040.USD","BK4588","LU0320765992.SGD","IE0009355771.USD","TBXU","IE00BJT1NW94.SGD","BK4585","IE00BFTCPJ56.SGD","ARGX","LU1983260115.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660433030","title":"Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660433030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660433030?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:11","pubTimestamp":1786975871,"startTime":"0","endTime":"0","summary":"Argenx SE stock was up 15.25% on Monday after the company posted results from its ALKIVIA Phase 3 study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/argenx-se-argx-stock-soars-15-on-positive-phase-3-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/argenx-se-argx-stock-soars-15-on-positive-phase-3-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4588","TBXU","LU0109394709.USD","BK4139","LU2324357040.USD","IE00B4R5TH58.HKD","BK4505","FMED","ARGX","BK4585","IE0009355771.USD","IE00B2B36J28.USD","IE0034235188.USD","LU0320765992.SGD","LU0823416689.USD","LU1983260115.SGD","LU0889565916.HKD","IBB","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660433417","title":"Argenx SE up over 15%, on Pace for Largest Percent Increase Since July 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2660433417","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660433417?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:08","pubTimestamp":1786975680,"startTime":"0","endTime":"0","summary":"argenx SE Sponsored ADR  is currently at $979.54, up $128.25 or 15.07%--Would be new all-time closing high --Would be the first record close since July 2, 2026, when it closed at $939.68--On pace for largest percent increase since July 17, 2023, when it rose 27.79%--Snaps a two day losing streak--Up 14.72% month-to-date--Up 16.48% year-to-date--Up 48.12% from 52 weeks ago , when it closed at $661.32--Would be a new 52-week closing high--Up 49.12% from its 52-week closing low of $656.89 on Aug. 19, 2025--Traded as high as $982.95; new all-time intraday high --Up 15.47% at today's intraday high; largest intraday percent increase since July 17, 2023, when it rose as much as 31.54%All data as of 10:02:39 AM ETSource: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IBB","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4139","IE00BJT1NW94.SGD","IE0002141913.USD","BK4585","ARGX","TBXU","IE0034235188.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0009355771.USD","FMED","BK4505","LU1983260115.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0823416689.USD","LU2324357040.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660743398","title":"Argenx rises 14.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660743398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660743398?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:00","pubTimestamp":1786975211,"startTime":"0","endTime":"0","summary":"Argenx (ARGX) is up 14.9%, or $126.60 to $977.89. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-rises-14-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-rises-14-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1983260115.SGD","LU0823416689.USD","TBXU","ARGX","IE00B2B36J28.USD","LU2324357040.USD","IBB","IE0009355771.USD","IE00B4R5TH58.HKD","BK4588","FMED","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","IE0034235188.USD","BK4139","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480066","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480066?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:04","pubTimestamp":1786971840,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Monday, with the State Street Health Care Select Sector SPDR ETF  0.5% lower and the iShares Biotechnology ETF  up 0.2%.Argenx  shares were nearly 12% higher after the company said a phase 3 study evaluating its experimental drug, Vyvgart Hytrulo, in adults with autoimmune myositis met its main goal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B64PRP62.GBP","IE0034235188.USD","IE00B3QW5Z07.USD","FMED","LU1883839398.USD","BK4137","IBB","LU0061475181.USD","BK4139","LU1983260115.SGD","BK4505","LU0029874061.USD","ARGX","BK4550","BK4585","STT","LU0823416689.USD","IE00BGHQF748.EUR","LU0109394709.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","TBXU","BK4135","IE0002141913.USD","LU0320765992.SGD","LU2324357040.USD","IE00BFTCPJ56.SGD","LABU","BK4588","IE00BJJMRZ35.SGD","LU1894683264.USD","XLV","XBI","BK4581","IE00B2B36J28.USD","IE0009355771.USD","HCSG","LU1894683348.USD","LU0128526141.USD","FDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484769","title":"Argenx price target raised to $1,215 from $1,075 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484769?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:13","pubTimestamp":1786965211,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Argenx (ARGX) to $1,215 from $1,075 and keeps an Overweight rating on the shares. With Q2 2026 repo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1215-from-1075-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1215-from-1075-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IE00B2B36J28.USD","LU2324357040.USD","LU1983260115.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","FMED","BK4588","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","TBXU","BK4505","IE0034235188.USD","LU0320765992.SGD","BK4585","ARGX","LU0823416689.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483685","title":"argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483685","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483685?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:25","pubTimestamp":1786955131,"startTime":"0","endTime":"0","summary":"argenx  said a phase 3 study evaluating its experimental drug, Vyvgart Hytrulo, in adults with autoimmune myositis met main goal.The company said the patients treated with the drug showed a statistically significant improvement in mean total improvement score at week 52 compared with placebo.Treatment benefits emerged as early as week 4 and were sustained through the 52-week treatment period, including during steroid tapering, the company said.argenx said the primary endpoint was also met in patients with immune-mediated necrotizing myopathy, while dermatomyositis patients showed a similar improvement, although it did not reach statistical significance.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","ARGX","LU2324357040.USD","IE0009355771.USD","TBXU","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00BFTCPJ56.SGD","BK4588","BK4585","LU1983260115.SGD","IE00B2B36J28.USD","LU0889565916.HKD","IE0034235188.USD","IE00BJJMRZ35.SGD","BK4505","IE0002141913.USD","BK4139","IBB","FMED","LU0823416689.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660948803","title":"Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2660948803","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660948803?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:08","pubTimestamp":1786954080,"startTime":"0","endTime":"0","summary":"Shares in Argenx rose after the European pharmaceutical company reported positive results from the phase 3 trial of Efgartigimod for the treatment of autoimmune myositis.In early morning trading, shar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","ARGX","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0002141913.USD","LU2324357040.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4139","BK4585","IE00B4R5TH58.HKD","IE0034235188.USD","LU0823416689.USD","BK4588","LU0889565916.HKD","TBXU","LU1983260115.SGD","FMED","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0109394709.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660828109","title":"Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2660828109","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660828109?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:35","pubTimestamp":1786926913,"startTime":"0","endTime":"0","summary":"Thermo Fisher Scientific stock has delivered a 20.7% gain over the past year, and the latest checks suggest it now sits close to its estimated intrinsic value rather than looking clearly cheap or clearly expensive.\n\nThermo Fisher Scientific is up 20.7% over the past 12 months, which puts more focus on whether current buyers are paying a fair price for the cash flows that the business may generate.\nThe recent sale of the microbiology business and ongoing work in proteomics and precision...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/97023-main-header/1756189961534","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/97023-main-header/1756189961534"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-tmo-stock-may-be-8-below-fair-value-on-microbi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-tmo-stock-may-be-8-below-fair-value-on-microbi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BKPKM429.USD","LU0316494557.USD","IE00B19Z8X17.USD","IE00BQXX3D17.EUR","IE00B2B36J28.USD","LU0640476718.USD","LU1153585028.USD","LU1988902786.USD","LU2468319806.SGD","LU0070302665.USD","BK4581","LU2360108059.USD","LU2720916845.USD","LU0320765489.SGD","LU2063271972.USD","BK4533","LU2764263039.SGD","LU1854103824.USD","LU2764262908.HKD","LU0122379950.USD","LU0310800379.SGD","SPHQ","LU0128525929.USD","BK4534","IE00BJT1NW94.SGD","LU2092937221.SGD","LU0957791311.USD","BK4566","LU2041044095.USD","BK4535","LU0061474960.USD","LU1923622291.USD","IE00BQXX3F31.USD","LU1815333072.USD","IE00B19Z9505.USD","TMO","LU1720051017.SGD","FMED","TMED","LU2264538146.SGD","LU0345770308.USD","LU0011850046.USD","IE0034235188.USD","LU1712237335.SGD","LU1670628061.USD","IE00B1BXHZ80.USD","LU0114720955.EUR","HRTS","LU2125910336.SGD","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659794001","title":"Lifestance Health Q2 Call Highlights Profitable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659794001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659794001?lang=en_us&edition=fundamental","pubTime":"2026-08-16 08:15","pubTimestamp":1786839326,"startTime":"0","endTime":"0","summary":"Lifestance Health Group, Inc. (($LFST)) has held its Q2 earnings call. Read on for the main highlights of the call. Lifestance Health Group’s lates...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lifestance-health-q2-call-highlights-profitable-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lifestance-health-q2-call-highlights-profitable-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DECU","BK4196","LFST","VGFPF","GXDW","FEBU","FMED","JOYT","PMDE","BK4535","BK4539","VOTE","RGLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659272581","title":"Major Insider Move at Lifestance Health Group Shakes Up Investor Watchlists","url":"https://stock-news.laohu8.com/highlight/detail?id=2659272581","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659272581?lang=en_us&edition=fundamental","pubTime":"2026-08-15 10:12","pubTimestamp":1786759945,"startTime":"0","endTime":"0","summary":"New insider activity at Lifestance Health Group ( ($LFST) ) has taken place on August 14, 2026. Director Teresa DeLuca of Lifestance Health Group h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-lifestance-health-group-shakes-up-investor-watchlists-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-lifestance-health-group-shakes-up-investor-watchlists-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4196","FMED","LFST","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659241131","title":"LifeStance Health Director Teresa DeLuca Sells 20,441 Shares Worth $249,991.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2659241131","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659241131?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:51","pubTimestamp":1786744271,"startTime":"0","endTime":"0","summary":"LifeStance Health director Teresa DeLuca sells 20,441 shares worth $249,991.43LifeStance Health director Teresa DeLuca sold 20,441 common shares on Aug. 13, 2026 at USD 12.23.DeLuca held 104,593 share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4ZnLZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LifeStance Health Director Teresa DeLuca Sells 20,441 Shares Worth $249,991.43","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","BK4535","LFST","BK4539","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659217491","title":"Steris PLC Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2659217491","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659217491?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:06","pubTimestamp":1786741560,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  slid 1.18% to $233.28 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.17% to 7,785.76 and Dow Jones Industrial Average  falling 0.20% to 53,732.41.This was the stock's fourth consecutive day of losses.Steris PLC closed 13.42% short of its 52-week high of $269.44, which the company reached on January 16th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Thermo Fisher Scientific Inc.  fell 1.28% to $588.29, Danaher Corp.  fell 0.71% to $202.45, and Becton Dickinson & Co.  rose 0.79% to $183.40.Trading volume  remained 231,699 below its 50-day average volume of 811,394.Data source: Dow Jones Market Data, FactSet. Data compiled August 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861165.SGD","LU1623119135.USD","LU0320765489.SGD","IE0004445239.USD","LU1064131342.USD","LU1923621640.USD","LU1057294990.SGD","LU2089984988.USD","LU2125910179.SGD","LU0097036916.USD","HRTS","LU0345770993.USD","LU0114720955.EUR","FMED","BDX","LU0943347566.SGD","LU1571399168.USD","LU0985320562.USD","LU1804176565.USD","LU1023059063.AUD","SGXZ23171101.USD","GB00BDT5M118.USD","LU0477156797.USD","IE00BQXX3F31.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0096362180.USD","LU2211814178.USD","LU0957791311.USD","LU0310800379.SGD","IE00BKVL7J92.USD","LU2543165471.USD","LU2023250504.SGD","STE","LU1917777945.USD","LU0070302665.USD","LU1551013425.SGD","LU1061106388.HKD","LU2125910336.SGD","LU2360108059.USD","LU0057025933.USD","GNMX","TMO","LU1720051108.HKD","LU1854103824.USD","IHI","LU0006061336.USD","TMED","LU2468319806.SGD","DHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140268","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140268","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140268?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:08","pubTimestamp":1786720082,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.35% to 1,962.14 on the S&P Europe Select ADR Index, which is up 0.17% for the we","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","BK4201","AKTX","BPH","FTXN","FMED","SHEL","LU0889565916.HKD","BCYC","DBC","DRIP","EQNR","AFG","BK4107","EVAX","LU0320765646.SGD","ERX","SQNS","DBE","GUSH","USE","BP","AUTL","SHEH","ARGX","DBVT","NCNA","PXJ","IEO","NOK","TRIB","CLLS","LNOK","BK4547","WTIU","XES","EPV","IE0009355771.USD","VDE","PXE","IXC","IEUR","DIG","DRLL","LU1983260115.SGD","IBB","LU2324357040.USD","BDRX","E"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659948871","title":"Major Insider Move Shakes Up Lifestance Health Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2659948871","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659948871?lang=en_us&edition=fundamental","pubTime":"2026-08-14 10:03","pubTimestamp":1786673036,"startTime":"0","endTime":"0","summary":"New insider activity at Lifestance Health Group ( ($LFST) ) has taken place on August 13, 2026. Director Kenneth Burdick has executed a major sale ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-lifestance-health-group-insider-trading-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-lifestance-health-group-insider-trading-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4535","LFST","BK4196","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659208162","title":"10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659208162","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659208162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:13","pubTimestamp":1786651992,"startTime":"0","endTime":"0","summary":"10x Genomics director John R. Stuelpnagel sells 20,000 shares worth $1.15 million10x Genomics director John R. Stuelpnagel sold 20,000 Class A common shares on Aug. 11, 2026.Sales priced at USD 57.58 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLZd8PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4548","LU1861558580.USD","FMED","TXG","LU1861559042.SGD","ARKG","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164067","title":"Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164067","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164067?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651375,"startTime":"0","endTime":"0","summary":"Thermo Fisher EVP Michael D. Shafer disposes of 25,500 common shares worth $15.3 million under 10b5-1 planThermo Fisher Executive Vice President Michael D. Shafer sold 25,500 shares on Aug. 11 at USD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2cbkgB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","BK4533","LU0310800379.SGD","LU2063271972.USD","LU0122379950.USD","LU0234572021.USD","HRTS","LU1720051017.SGD","LU1988902786.USD","LU2125909759.SGD","TMO","LU0345770308.USD","BK4548","LU2764263203.CNY","LU2298321311.HKD","LU2125909916.SGD","LU2089984988.USD","LU2041044095.USD","LU0432979614.USD","LU0320765489.SGD","IE00BQXX3D17.EUR","LU1670628061.USD","BK4585","IE00BJT1NW94.SGD","LU2211815571.USD","IE00BQXX3C00.GBP","LU1983299246.USD","LU0557290698.USD","LU1057294990.SGD","LU1633808545.USD","LU1791710582.SGD","IE00B19Z8W00.USD","LU2764263039.SGD","LU0096362180.USD","LU0708994859.HKD","LU2357305700.SGD","IE00B19Z9505.USD","LU1670627923.USD","LU1923622291.USD","BK4588","LU2125909247.SGD","LU0823416689.USD","LU0342679015.USD","GNMX","LU0029864427.USD","IE00BKPKM429.USD","TMED","LU1803068623.USD","LU1267930573.SGD","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659093166","title":"Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659093166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659093166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:31","pubTimestamp":1786638686,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. The new argenx study focuses on empasiprubart in adults with multifocal motor n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","IE00B4R5TH58.HKD","ARGX","LU0109394709.USD","LU0823416689.USD","FMED","IBB","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2324357040.USD","BK4211","IE00B2B36J28.USD","BK4588","IE0034235188.USD","LU1983260115.SGD","IE0009355771.USD","TBXU","BK4139","ISBC","BK4585","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188032","title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188032","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188032?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:00","pubTimestamp":1786568426,"startTime":"0","endTime":"0","summary":"LifeStance COO Lisa K. Miller disposes of 47,912 common shares worth $519,245.20LifeStance Health COO Lisa K. Miller sold 47,912 common shares on Aug. 10 at USD 10.85.Direct holding fell to 281,289 sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL98VmhP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4535","BK4196","FMED","LFST"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}